Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest VRML Stories

2014-03-03 16:25:49

AUSTIN, Texas, March 3, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has been invited to present at ROTH Capital Partners 26th Annual Conference being held March 10-12, 2014, at the Ritz-Carlton in Dana Point, California. President and CEO of Vermillion, Thomas McLain, is scheduled to present on Tuesday, March 11, 2014, at 3:30 p.m. Pacific time, with one-on-one meetings held throughout the...

2014-02-26 16:28:51

AUSTIN, Texas, Feb. 26, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Thursday, March 6, 2014, at 4:30 p.m. Eastern time to discuss results for the fourth quarter and year ended December 31, 2013. Financial results will be issued in a press release prior to the call. Vermillion's President and CEO Thomas McLain will host the call, followed by a question and...

2014-01-31 08:25:43

AUSTIN, Texas, Jan. 31, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has been invited to present at Leerink Partners' Global Healthcare Conference. The conference will be held at the Waldorf Astoria Hotel in New York City from February 12-13, 2014. President and CEO of Vermillion, Thomas McLain, is scheduled to present on Thursday, February 13, 2014 at 3:05 p.m. Eastern time. He will be...

2013-12-16 16:25:42

AUSTIN, Texas, Dec. 16, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported the voting results from its annual meeting of its stockholders held December 12, 2013: -- Approved the reappointment of Peter S. Roddy as director -- Approved in an advisory vote the compensation of the company's named executive officers -- Ratified the appointment of BDO USA, LLP as the company's...

2013-10-31 08:34:03

AUSTIN, Texas, Oct. 31, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Thursday, November 14, 2013, at 4:30 p.m. Eastern time to discuss results for the third quarter ended September 30, 2013. Financial results will be issued in a press release prior to the call. Vermillion's President and CEO Thomas McLain will host the call, followed by a question and answer...

2013-10-14 08:25:08

AUSTIN, Texas, Oct. 14, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold its 2013 Annual Meeting of Stockholders on Thursday, December 12, 2013 at 8:00 a.m. Central time at the Marriott Hotel located at 300 East Fourth Street in Austin, Texas 78701. About VermillionVermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value...

2013-09-16 16:25:15

AUSTIN, Texas, Sept. 16, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, today announced the appointment of Eric Varma, M.D. to its board of directors. "As a partner at Oracle Investment Management, Vermillion's largest shareholder, and a physician, Eric brings significant financial and commercial experience in the life sciences to our board of directors," said Thomas McLain, Vermillion's...

2013-07-31 08:30:44

AUSTIN, Texas, July 31, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Wednesday, August 14, 2013, at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2013. Financial results will be issued in a press release prior to the call. Vermillion's President and CEO Thomas McLain will host the call, followed by a question and answer...

2013-05-01 08:31:51

AUSTIN, Texas, May 1, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Wednesday, May 15, 2013, at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2013. Financial results will be issued in a press release prior to the call. Vermillion's President and CEO Thomas McLain will host the call, followed by a question and answer period. Date:...

2013-02-19 12:31:16

AUSTIN, Texas, Feb. 19, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focused on gynecologic cancers and vascular medicine, will hold a conference call on Wednesday, February 20, 2013, at 4:30 p.m. ET to discuss full results for its fourth quarter and year ended December 31, 2012. While previously expecting to report only preliminary results on this date, the company recently received its annual 'true-up' of OVA1 sales from Quest Diagnostics ahead of...